デフォルト表紙
市場調査レポート
商品コード
1446969

高圧造影剤注入器の2030年までの世界市場予測:製品タイプ、用途、エンドユーザー、地域別分析

High Pressure Contrast Media Injector Market Forecasts to 2030 - Global Analysis By Product (Injector Systems and Consumables), Type (Single Head Injectors, Syringeless Injectors and Dual Head Injectors), Application, End User and By Geography

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.89円
高圧造影剤注入器の2030年までの世界市場予測:製品タイプ、用途、エンドユーザー、地域別分析
出版日: 2024年03月03日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、高圧造影剤注入器の世界市場は2023年に1億7,760万米ドルを占め、予測期間中のCAGRは14.1%で成長し、2030年には4億4,720万米ドルに達する見込みです。

高圧造影剤注入器は、放射線学および画像診断手順、特にコンピュータ断層撮影(CT)スキャンや血管造影で使用される医療機器です。この装置は通常、造影剤を入れたシリンジまたはリザーバー、高圧注入器システム、コンピュータ制御パネルで構成されています。これらの注入器は、造影剤を制御された速度と圧力で送り出し、血管系全体に一貫した均一な分布を確保します。その結果、血管、臓器、組織の可視性が向上し、より鮮明で詳細な画像が得られます。

世界保健機関(WHO)の推計によると、がんは世界の大半の国で主要な死因の一つです。

低侵襲手術に対する需要の高まり

低侵襲手術手技は、従来の開腹手術と比較してその潜在的な利点から人気を博しています。低侵襲手術が様々な医療分野で普及するにつれて、これらの手術中の高品質な画像ガイダンスの必要性が最も重要になります。さらに、高圧造影剤注入装置は、血管内治療、インターベンショナル・ラジオロジー、腹腔鏡手術などの低侵襲手術において、血管、臓器、組織をリアルタイムで可視化する上で重要な役割を果たしています。

有害事象のリスク

高圧造影剤注入器は、造影剤を患者の血流に直接投与する医療機器です。そのため、アレルギー反応、血管外浸潤、アナフィラキシーなど、造影剤投与に伴う有害事象のリスクがあります。さらに、造影剤腎症は、特に腎障害の既往がある患者において、造影剤曝露後の急性腎障害を特徴とする潜在的な合併症です。有害事象の発生は、患者への危害、ヘルスケアコストの増加、医療提供者や医療施設の責任リスクにつながる可能性があります。こうした要因が市場の拡大を制限しています。

画像技術の進歩

画像技術が進化し高度化するにつれて、詳細で正確な診断情報を提供するための造影画像処置の必要性が高まっています。高圧造影剤注入器は、造影剤を患者の血流に正確かつ制御された形で確実に送り込むことができるため、造影剤強化イメージング手技に不可欠なコンポーネントです。さらに、造影剤を高圧かつ制御された速度で注入することにより、血管系全体への造影剤の分布が最適化され、解剖学的構造や異常の明瞭な可視化が可能になります。その結果、画像処理技術の進歩が市場拡大の大きな要因となっています。

代替画像モダリティとの競合

超音波、磁気共鳴画像法(MRI)、光干渉断層計(OCT)などのモダリティは、造影剤を注射することなく詳細な解剖学的・機能的情報を提供します。これらの代替画像診断法は、造影剤を使用した画像診断法と比較して、副作用のリスクの低減や電離放射線被曝の回避などの利点があります。その結果、ヘルスケア・プロバイダーは、造影剤注入法よりも代替画像診断法を選択することが増え、高圧造影剤注入器の需要減少につながる可能性があります。

COVID-19の影響

COVID-19の大流行は、高圧造影剤注入器市場にマイナスの影響を与えました。世界中のヘルスケアシステムがCOVID-19患者の流入に圧倒され、画像診断を含む緊急性のない医療処置が延期またはキャンセルされ、造影剤注入器の需要減少につながった。さらに、多くの病院や画像診断センターが、人員不足、サプライチェーンの混乱、財政的制約などの運営上の課題に直面しています。

予測期間中、消耗品セグメントが最大となる見込み

消耗品セグメントは最大のシェアを占めると推定されます。消耗品は、造影剤注入システムの操作と機能をサポートする上で重要な役割を果たします。シリンジは、造影剤を保持し、注入システムに供給するために不可欠な消耗品です。さらに、さまざまな注入量や流量に対応できるよう、さまざまなサイズや構成があります。その結果、消耗品の需要は一貫しており、臨床における高圧造影剤注入器の使用と密接な関係があります。

予測期間中、シングルヘッド注入器セグメントが最も高いCAGRが見込まれる

シングルヘッド注入器セグメントは、予測期間中に有利な成長を遂げると予測されています。これらの注入器は、単一の注入ヘッドまたはシリンジを通して、制御された速度と圧力で患者の血流に造影剤を供給するように設計されています。さらに、これらの注入器はシンプルで使いやすいため、ヘルスケア環境でのルーチン画像処理に適しています。これらの注入器は、正確な量の造影剤を最小限のばらつきで供給するように設計されており、画像検査において一貫した画質と診断精度を保証します。

最もシェアの高い地域

北米は、先進的なヘルスケアインフラ、技術革新、画像診断に対する高い需要を背景に、予測期間中に最大の市場シェアを獲得しました。この地域には米国、カナダ、メキシコが含まれ、医療支出が大きく、医療の進歩と患者のケアに重点が置かれています。さらに、北米における技術の進歩や研究開発の取り組みは、高圧造影剤注入器技術の継続的な進化に寄与しています。

CAGRが最も高い地域:

欧州は予測期間中に収益性の高い成長を遂げることが予想されます。欧州のヘルスケアインフラは、確立された病院、画像診断センター、学術機関によって特徴付けられ、最先端の画像診断手順へのアクセスを提供しています。さらに、この地域には、高圧造影剤注入器などの医療機器の大手メーカーが数社あります。これらの企業は、この地域の強力な研究開発能力、規制に関する専門知識、品質基準を活用し、医療従事者や患者のニーズを満たす革新的な注入器技術を開発しています。

無料カスタマイズサービス:

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます:

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング(3社まで)
    • 主要企業のSWOT分析(3社まで)
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR(注:フィージビリティチェックによる)
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 製品分析
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • 新型コロナウイルス感染症(COVID-19)の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の高圧造影剤注入器市場:製品別

  • 注入器システム
  • 消耗品
    • チューブ
    • シリンジ

第6章 世界の高圧造影剤注入器市場:タイプ別

  • シングルヘッド注入器
  • シリンジレス注入器
  • デュアルヘッド注入器

第7章 世界の高圧造影剤注入器市場:用途別

  • インターベンション放射線学
  • 血管内手術
  • インターベンション心臓学
  • その他の用途

第8章 世界の高圧造影剤注入器市場:エンドユーザー別

  • 外来手術センター
  • 病院
  • 診断センター

第9章 世界の高圧造影剤注入器市場:地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第10章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第11章 企業プロファイル

  • Guerbet Group
  • Bayers Healthcare LLC
  • Bracco Group
  • Ulrich GmbH & Co. KG
  • Medtron AG
  • GE Healthcare
  • NemotoKyorindo Co. Ltd
  • Apollo RT Co. Ltd
  • Vivid Imaging
  • Sino Medical Device Technology Co.
図表

List of Tables

  • Table 1 Global High Pressure Contrast Media Injector Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 4 Global High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 6 Global High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 7 Global High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 8 Global High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 9 Global High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 10 Global High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 11 Global High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 13 Global High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 14 Global High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 15 Global High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 16 Global High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 17 Global High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 18 Global High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 19 Global High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 20 North America High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 21 North America High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 22 North America High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 23 North America High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 24 North America High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 25 North America High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 26 North America High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 28 North America High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 29 North America High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 30 North America High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 31 North America High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 32 North America High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 33 North America High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 34 North America High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 35 North America High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 36 North America High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 37 North America High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 38 North America High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 39 Europe High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 40 Europe High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 41 Europe High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 42 Europe High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 43 Europe High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 44 Europe High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 45 Europe High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 46 Europe High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 47 Europe High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 48 Europe High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 49 Europe High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 50 Europe High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 51 Europe High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 52 Europe High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 53 Europe High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 54 Europe High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 55 Europe High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 56 Europe High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 57 Europe High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 58 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 59 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 60 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 61 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 62 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 63 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 64 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 65 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 66 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 67 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 68 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 69 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 70 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 71 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 72 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 73 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 74 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 75 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 76 Asia Pacific High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 77 South America High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 78 South America High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 79 South America High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 80 South America High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 81 South America High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 82 South America High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 83 South America High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 84 South America High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 85 South America High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 86 South America High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 87 South America High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 88 South America High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 89 South America High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 90 South America High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 91 South America High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 92 South America High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 93 South America High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 94 South America High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 95 South America High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 96 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Country (2021-2030) ($MN)
  • Table 97 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Product (2021-2030) ($MN)
  • Table 98 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Injector Systems (2021-2030) ($MN)
  • Table 99 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 100 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Tubing (2021-2030) ($MN)
  • Table 101 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Syringes (2021-2030) ($MN)
  • Table 102 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Type (2021-2030) ($MN)
  • Table 103 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Single Head Injectors (2021-2030) ($MN)
  • Table 104 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Syringeless Injectors (2021-2030) ($MN)
  • Table 105 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Dual Head Injectors (2021-2030) ($MN)
  • Table 106 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Application (2021-2030) ($MN)
  • Table 107 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Interventional Radiology (2021-2030) ($MN)
  • Table 108 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Endovascular Surgery (2021-2030) ($MN)
  • Table 109 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Interventional Cardiology (2021-2030) ($MN)
  • Table 110 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 111 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By End User (2021-2030) ($MN)
  • Table 112 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 113 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 114 Middle East & Africa High Pressure Contrast Media Injector Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
目次
Product Code: SMRC25230

According to Stratistics MRC, the Global High Pressure Contrast Media Injector Market is accounted for $177.6 million in 2023 and is expected to reach $447.2 million by 2030 growing at a CAGR of 14.1% during the forecast period. A high-pressure contrast media injector is a medical device used in radiology and diagnostic imaging procedures, particularly computed tomography (CT) scans and angiography. The device typically consists of a syringe or reservoir containing the contrast media, a high-pressure injector system, and a computerized control panel. These injectors deliver contrast media at a controlled rate and pressure, ensuring consistent and uniform distribution throughout the vascular system. This results in improved visualization of blood vessels, organs, and tissues, leading to clearer and more detailed images.

According to the World Health Organization (WHO) estimates, cancer is the one of the leading causes of death in majority of countries globally.

Market Dynamics:

Driver:

Rising demand for minimally invasive surgeries

Minimally invasive surgical techniques have gained popularity due to their potential benefits compared to traditional open surgeries. As minimally invasive procedures become more widespread across various medical specialties, the need for high-quality imaging guidance during these procedures becomes paramount. Additionally, high-pressure contrast media injectors play a crucial role in providing real-time visualization of blood vessels, organs, and tissues during minimally invasive surgeries, such as endovascular procedures, interventional radiology, and laparoscopic surgeries.

Restraint:

Risk of adverse events

High-pressure contrast media injectors are medical devices that administer contrast agents directly into the patient's bloodstream. As such, there is a risk of adverse events associated with contrast administration, such as allergic reactions, extravasation, and anaphylaxis. Furthermore, contrast-induced nephropathy is a potential complication characterized by acute kidney injury following contrast media exposure, particularly in patients with pre-existing renal impairment. The occurrence of adverse events can result in patient harm, increased healthcare costs, and liability risks for healthcare providers and facilities. These factors limit the market's expansion.

Opportunity:

Advancements in imaging technologies

As imaging technologies evolve and become more sophisticated, there is a growing need for contrast-enhanced imaging procedures to provide detailed and accurate diagnostic information. High-pressure contrast media injectors are essential components in contrast-enhanced imaging procedures, as they ensure the precise and controlled delivery of contrast agents into the patient's bloodstream. Moreover, by delivering contrast media at high pressures and controlled rates, these injectors optimize the distribution of contrast agents throughout the vascular system, enabling clearer visualization of anatomical structures and abnormalities. As a result, advancements in imaging technologies are a significant factor propelling market expansion.

Threat:

Competition from alternative imaging modalities

Modalities such as ultrasound, magnetic resonance imaging (MRI), and optical coherence tomography (OCT) provide detailed anatomical and functional information without the need for Injectable contrast media. These alternative imaging modalities offer advantages over contrast-enhanced imaging techniques, including reduced risk of adverse reactions and avoidance of ionizing radiation exposure. As a result, healthcare providers may increasingly opt for alternative imaging modalities over contrast-enhanced techniques, leading to a decline in demand for high-pressure contrast media injectors.

Covid-19 Impact

The COVID-19 pandemic had negatively impacted the high-pressure contrast media injector market. With healthcare systems worldwide overwhelmed by the influx of COVID-19 patients, non-urgent medical procedures, including diagnostic imaging, have been postponed or cancelled, leading to a decline in demand for contrast media injectors. Moreover, many hospitals and imaging centers faced operational challenges, such as staffing shortages, supply chain disruptions, and financial constraints.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is estimated to hold the largest share. Consumables play a crucial role in supporting the operation and functionality of contrast media injection systems. Syringes are essential consumables that hold and deliver the contrast media to the injector system. Moreover, they come in various sizes and configurations to accommodate different injection volumes and flow rates. As a result, demand for consumables remains consistent and is closely related to the use of high-pressure contrast media injectors in clinical practice.

The single head injectors segment is expected to have the highest CAGR during the forecast period

The single head injectors segment is anticipated to have lucrative growth during the forecast period. These injectors are designed to deliver contrast media into the patient's bloodstream at a controlled rate and pressure through a single injection head or syringe. Furthermore, these injectors offer simplicity and ease of use, making them suitable for routine imaging procedures in healthcare settings. They are engineered to deliver precise volumes of contrast media with minimal variability, ensuring consistent image quality and diagnostic accuracy across imaging studies.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to its advanced healthcare infrastructure, technological innovation, and high demand for diagnostic imaging procedures. The region encompasses the United States, Canada, and Mexico, where healthcare expenditure is substantial and there is a strong emphasis on medical advancements and patient care. Moreover, technological advancements and research and development initiatives in North America contribute to the continuous evolution of high-pressure contrast media injector technologies.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. Europe's healthcare infrastructure is characterized by well-established hospitals, imaging centers, and academic institutions, providing access to state-of-the-art diagnostic imaging procedures. Furthermore, the region is home to several leading manufacturers of medical devices, including high-pressure contrast media injectors. These companies leverage the region's strong research and development capabilities, regulatory expertise, and quality standards to develop innovative injector technologies that meet the needs of healthcare providers and patients.

Key players in the market

Some of the key players in the High Pressure Contrast Media Injector Market include Guerbet Group, Bayers Healthcare LLC, Bracco Group, Ulrich GmbH & Co. KG, Medtron AG, GE Healthcare, NemotoKyorindo Co. Ltd, Apollo RT Co. Ltd, Vivid Imaging and Sino Medical Device Technology Co.

Key Developments:

In September 2023, GE HealthCare and Mayo Clinic announced a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.

In December 2022, Bayer announced the U.S. launch of the Bayer Science Collaboration Explorer (BSCE) as part of its ongoing efforts to enhance public trust in scientific innovations, processes, and R&D activities.

In November 2022, GE Healthcare announced agreement with ulrich medical aimed at enhancing its market position in the growing U.S. market. As per the agreement, these two companies will co-ordinate to develop and offer multi-dose contrast media injector in the country.

In March 2022, Bracco Imaging and Philochem, a subsidiary of the Philogen Group collaborated on the development of a molecule for diagnostic applications

In December 2021, Bracco Imaging announced a global strategic collaboration agreement with Guerbet for Gadopiclenol, a high-relaxivity, macrocyclic contrast agent. Bracco Imaging and Guerbet will manufacture, as well as support research and development for future indications of Gadopiclenol, which the parties will commercialize independently under different brands.

Products Covered:

  • Injector Systems
  • Consumables

Types Covered:

  • Single Head Injectors
  • Syringeless Injectors
  • Dual Head Injectors

Applications Covered:

  • Interventional Radiology
  • Endovascular Surgery
  • Interventional Cardiology
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Diagnostic Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global High Pressure Contrast Media Injector Market, By Product

  • 5.1 Introduction
  • 5.2 Injector Systems
  • 5.3 Consumables
    • 5.3.1 Tubing
    • 5.3.2 Syringes

6 Global High Pressure Contrast Media Injector Market, By Type

  • 6.1 Introduction
  • 6.2 Single Head Injectors
  • 6.3 Syringeless Injectors
  • 6.4 Dual Head Injectors

7 Global High Pressure Contrast Media Injector Market, By Application

  • 7.1 Introduction
  • 7.2 Interventional Radiology
  • 7.3 Endovascular Surgery
  • 7.4 Interventional Cardiology
  • 7.5 Other Applications

8 Global High Pressure Contrast Media Injector Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Diagnostic Centers

9 Global High Pressure Contrast Media Injector Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Guerbet Group
  • 11.2 Bayers Healthcare LLC
  • 11.3 Bracco Group
  • 11.4 Ulrich GmbH & Co. KG
  • 11.5 Medtron AG
  • 11.6 GE Healthcare
  • 11.7 NemotoKyorindo Co. Ltd
  • 11.8 Apollo RT Co. Ltd
  • 11.9 Vivid Imaging
  • 11.10 Sino Medical Device Technology Co.